US Stock MarketDetailed Quotes

ANEB Anebulo Pharmaceuticals

Watchlist

2.330
-0.070-2.92%

Trading Jul 25 09:30 ET

60.42MMarket Cap-6297P/E (TTM)

Anebulo Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Mar 31, 2024

(Q2)Dec 31, 2023

(Q1)Sep 30, 2023

(FY)Jun 30, 2023

(Q4)Jun 30, 2023

(Q3)Mar 31, 2023

(Q2)Dec 31, 2022

(Q1)Sep 30, 2022

(FY)Jun 30, 2022

(Q4)Jun 30, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-63.66%5.15M

-59.37%6.64M

-55.65%8.52M

-22.69%11.25M

-14.40%14.16M

-9.18%16.36M

0.03%19.21M

-27.21%14.55M

-Cash and cash equivalents

-63.66%5.15M

-59.37%6.64M

-55.65%8.52M

-22.69%11.25M

-14.40%14.16M

-9.18%16.36M

0.03%19.21M

-27.21%14.55M

Prepaid assets

-16.48%223.68K

-67.77%171.74K

-12.36%527.31K

-58.99%422.75K

-61.78%267.8K

-44.19%532.91K

-53.45%601.67K

-38.19%1.03M

Total current assets

-62.79%5.37M

-59.64%6.82M

-54.34%9.05M

-25.09%11.67M

-16.33%14.43M

-10.95%16.89M

-3.34%19.82M

-28.05%15.58M

Non current assets

Other non current assets

--624.82K

--684.52K

----

Total non current assets

--624.82K

--684.52K

--0

Total assets

-58.46%6M

-55.59%7.5M

-54.34%9.05M

-25.09%11.67M

-16.33%14.43M

-10.95%16.89M

-3.34%19.82M

-28.05%15.58M

Liabilities

Current liabilities

Payables

-32.58%384.92K

-8.04%318.68K

8.11%565.95K

40.36%534.55K

585.55%570.9K

706.99%346.55K

6.01%523.47K

246.06%380.83K

-accounts payable

-32.58%384.92K

-8.04%318.68K

8.11%565.95K

40.36%534.55K

585.55%570.9K

706.99%346.55K

6.01%523.47K

246.06%380.83K

Current accrued expenses

-32.04%625.4K

-32.26%694.88K

-13.79%150.61K

305.65%534.26K

36,707.32%920.18K

14,554.96%1.03M

53.40%174.71K

0.09%131.7K

Current liabilities

-32.24%1.01M

-26.15%1.01M

2.63%716.56K

108.53%1.07M

1,638.33%1.49M

2,647.88%1.37M

14.89%698.18K

112.11%512.53K

Non current liabilities

Total non current liabilities

--0

Total liabilities

-32.24%1.01M

-26.15%1.01M

2.63%716.56K

108.53%1.07M

1,638.33%1.49M

2,647.88%1.37M

14.89%698.18K

112.11%512.53K

Shareholders'equity

Share capital

1.17%25.93K

0.00%25.63K

9.81%25.63K

0.00%23.35K

-common stock

1.17%25.93K

0.00%25.63K

9.81%25.63K

0.00%23.35K

-Preferred stock

--0

Retained earnings

-17.09%-64.05M

-20.21%-62.4M

-24.13%-59.68M

-25.80%-57.2M

-26.79%-54.71M

-25.78%-51.91M

-19.61%-48.08M

-17.66%-45.47M

Paid-in capital

2.06%69.01M

2.17%68.86M

1.21%67.99M

12.00%67.78M

12.17%67.62M

12.03%67.4M

11.83%67.17M

0.80%60.51M

Total stockholders'equity

-61.48%4.99M

-58.19%6.49M

-56.42%8.33M

-29.64%10.6M

-24.60%12.94M

-17.97%15.52M

-3.90%19.12M

-29.63%15.07M

Total equity

-61.48%4.99M

-58.19%6.49M

-56.42%8.33M

-29.64%10.6M

-24.60%12.94M

-17.97%15.52M

-3.90%19.12M

-29.63%15.07M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Mar 31, 2024	(Q2)Dec 31, 2023	(Q1)Sep 30, 2023	(FY)Jun 30, 2023	(Q4)Jun 30, 2023	(Q3)Mar 31, 2023	(Q2)Dec 31, 2022	(Q1)Sep 30, 2022	(FY)Jun 30, 2022	(Q4)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-63.66%5.15M	-59.37%6.64M	-55.65%8.52M	-22.69%11.25M	-22.69%11.25M	-14.40%14.16M	-9.18%16.36M	0.03%19.21M	-27.21%14.55M	-27.21%14.55M
-Cash and cash equivalents	-63.66%5.15M	-59.37%6.64M	-55.65%8.52M	-22.69%11.25M	-22.69%11.25M	-14.40%14.16M	-9.18%16.36M	0.03%19.21M	-27.21%14.55M	-27.21%14.55M
Prepaid assets	-16.48%223.68K	-67.77%171.74K	-12.36%527.31K	-58.99%422.75K	-58.99%422.75K	-61.78%267.8K	-44.19%532.91K	-53.45%601.67K	-38.19%1.03M	-38.19%1.03M
Total current assets	-62.79%5.37M	-59.64%6.82M	-54.34%9.05M	-25.09%11.67M	-25.09%11.67M	-16.33%14.43M	-10.95%16.89M	-3.34%19.82M	-28.05%15.58M	-28.05%15.58M
Non current assets
Other non current assets	--624.82K	--684.52K	----	----	----	----	----	----	----	----
Total non current assets	--624.82K	--684.52K	--0	--0	--0	--0	--0	--0	--0	--0
Total assets	-58.46%6M	-55.59%7.5M	-54.34%9.05M	-25.09%11.67M	-25.09%11.67M	-16.33%14.43M	-10.95%16.89M	-3.34%19.82M	-28.05%15.58M	-28.05%15.58M
Liabilities
Current liabilities
Payables	-32.58%384.92K	-8.04%318.68K	8.11%565.95K	40.36%534.55K	40.36%534.55K	585.55%570.9K	706.99%346.55K	6.01%523.47K	246.06%380.83K	246.06%380.83K
-accounts payable	-32.58%384.92K	-8.04%318.68K	8.11%565.95K	40.36%534.55K	40.36%534.55K	585.55%570.9K	706.99%346.55K	6.01%523.47K	246.06%380.83K	246.06%380.83K
Current accrued expenses	-32.04%625.4K	-32.26%694.88K	-13.79%150.61K	305.65%534.26K	305.65%534.26K	36,707.32%920.18K	14,554.96%1.03M	53.40%174.71K	0.09%131.7K	0.09%131.7K
Current liabilities	-32.24%1.01M	-26.15%1.01M	2.63%716.56K	108.53%1.07M	108.53%1.07M	1,638.33%1.49M	2,647.88%1.37M	14.89%698.18K	112.11%512.53K	112.11%512.53K
Non current liabilities
Total non current liabilities	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Total liabilities	-32.24%1.01M	-26.15%1.01M	2.63%716.56K	108.53%1.07M	108.53%1.07M	1,638.33%1.49M	2,647.88%1.37M	14.89%698.18K	112.11%512.53K	112.11%512.53K
Shareholders'equity
Share capital	1.17%25.93K	1.17%25.93K	0.00%25.63K	9.81%25.63K	9.81%25.63K	9.81%25.63K	9.81%25.63K	9.81%25.63K	0.00%23.35K	0.00%23.35K
-common stock	1.17%25.93K	1.17%25.93K	0.00%25.63K	9.81%25.63K	9.81%25.63K	9.81%25.63K	9.81%25.63K	9.81%25.63K	0.00%23.35K	0.00%23.35K
-Preferred stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Retained earnings	-17.09%-64.05M	-20.21%-62.4M	-24.13%-59.68M	-25.80%-57.2M	-25.80%-57.2M	-26.79%-54.71M	-25.78%-51.91M	-19.61%-48.08M	-17.66%-45.47M	-17.66%-45.47M
Paid-in capital	2.06%69.01M	2.17%68.86M	1.21%67.99M	12.00%67.78M	12.00%67.78M	12.17%67.62M	12.03%67.4M	11.83%67.17M	0.80%60.51M	0.80%60.51M
Total stockholders'equity	-61.48%4.99M	-58.19%6.49M	-56.42%8.33M	-29.64%10.6M	-29.64%10.6M	-24.60%12.94M	-17.97%15.52M	-3.90%19.12M	-29.63%15.07M	-29.63%15.07M
Total equity	-61.48%4.99M	-58.19%6.49M	-56.42%8.33M	-29.64%10.6M	-29.64%10.6M	-24.60%12.94M	-17.97%15.52M	-3.90%19.12M	-29.63%15.07M	-29.63%15.07M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall